Calviri Calviri is a company that develops diagnostic and therapeutic products, as well as vaccines aimed to prevent cancer. | Isotopen Technologien Munchen ITM Isotopen Technologien Munchen is a company that develops, produces, and supplies diagnostic and therapeutic radionuclides and radiopharmaceuticals for use in cancer treatment. | |||
Founding Date | Founding Date 2000 | Founding Date 1997 | Founding Date 2018 | Founding Date 2004 |
Type | Type Private | Type Public | Type Private | Type Private |
Tags | ||||
Locations | Locations Columbia, US HQ | Locations Lund, SE HQ | Locations Phoenix, US HQ | Locations Garching bei München, DE HQ München, DE |
Employees | Employees 2 | Employees 118 | Employees 16 | Employees 5403% increase |
Funding | ||||
Latest funding round | Latest funding round $ 100k (about 16 years ago) | Latest funding round N/A | Latest funding round $ 2.3m (over 6 years ago) | Latest funding round $ 22m (over 10 years ago) |
Total funding raised | Total funding raised $ 2.1m | Total funding raised N/A | Total funding raised $ 2.3m | Total funding raised $ 22m |

BioInvent focuses on the discovery and development of antibody-based drugs against cancer.
View companyCalviri is a company that develops diagnostic and therapeutic products, as well as vaccines aimed to prevent cancer.
View companyITM Isotopen Technologien Munchen is a company that develops, produces, and supplies diagnostic and therapeutic radionuclides and radiopharmaceuticals for use in cancer treatment.
View company